Glucerna® Abbott Nutrition© Todos os direitos reservados
REFERÊNCIAS GLUCERNA SR:
*Glucerna SR é indicado para o controle do diabetes e Glucerna 1.5 é indicado para o controle da Glicemia. Associado ao uso correto da medicação, hábitos de vida saudáveis e alimentação adequada. **Foi demonstrado que a Glucerna reduz os aumentos pós-prandiais da glicemia quando usada como substituto de refeição (Davila et al., 2019; Devittet al., 2012; Luoet al., 2012; Mottalibet al., 2016)
1 - Devitt et al. Glycemia Targeted Specialized Nutrition (GTSN) improves postprandial glycaemia and GLP-1 with similar appetitive responses compared to a healthful whole food breakfast in persons with type 2 diabetes: a randomized, controlled trial. J Diabetes Res Clin Metab. 2012;1-20.
2 - Jenkins DJ, Taylor RH, Wolever TM. The diabetic diet, dietary carbohydrate and differences in digestibility. Diabetologia. 1982;23:477-484.
3 - Tatti et al. Effect of a low-calorie high nutritional value formula on weight loss in type 2 diabetes mellitus. Mediterr J Nutr Metab (2010) 3:65–69.
4 - Nutrition Recommendations and Interventions for Diabetes. A position statement of the American Diabetes Association. Diabetes Care, Volume 31, Supplement 1, January 2008.
5 - Sinclair, AJ; Paolisso G, et.al. European Diabetes Working Party for Older People (EDWPOP) Revision Group on Clinical Parctice Guidelines for type 2 Diabetes Mellitus. Diabetes & Metabolism. 2011, 37 S27 - S38.
6 - Davila Dávila, L. A., V. Bermúdez, D. Aparicio, V. Céspedes, M. C. Escobar, S. Durán-Agüero, S. Cisternas, J. de AssisCosta, D. Rojas-Gómez, N. Reyna and J. López-Miranda (2019). "Effect of oral nutritional supplements with sucromaltand isomaltuloseversus standard formula on glycaemicindex, entero-insular axis peptides and subjective appetite in patients with type 2 diabetes: A randomisedcross-over study." Nutrients 11(7): 1477.
7 - Devitt, A., S. Jeffery Oliver, A. RefaatHegazi and V. Mustad (2012). "Glycemia Targeted Specialized Nutrition (GTSN) improves postprandial glycemia and GLP-1 with similar appetitive responses compared to a healthful whole food breakfast in persons with type 2 diabetes: a randomized, controlled trial." Journal of Diabetes Research and Clinical Metabolism 1(1): 20.
8 - Luo, M., A. C. Voss, V. A. Mustad, L. Ivanova, T. Morugova, E. Alexeeva, L. Ruyatkinaand L. "Four-hour evaluation of a medical food in subjects with type 2 diabetes receiving oral hypoglycemic medication." Journal of Diabetes Mellitus 2(2): 214-220.
9 - Mottalib, A., B.-N. Mohd-Yusof, M. Shehabeldin, D. Pober, J. Mitriand O. Hamdy(2016). "Impact of diabetes-specific nutritional formulas versus oatmeal on postprandial glucose, insulin, GLP-1 and postprandial lipidemia." Nutrients 8(7): 443.
10 - Peng J, Lu J; et.al. Breakfast replacement with a liquid formula improves glycaemic variability in patients with type 2 diabetes: a randomised clinical trial. British Journal of Nutrition (2019), 121, 560–566.
REFERÊNCIAS GLUCERNA FIT:
1 - Xavier Pi-Sunyer, George Blackburn. et.al. Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes. One-year results of the Look AHEAD trial. Diabetes Care 2007 Jun; 30(6): 1374-1383.
2 - Wadden, T; West, D; et.al. One-Year Weight Losses in the Look AHEAD Study: Factors Associated with Success. Obesity (Silver Spring). 2009;17(4):713–722.
3 - Wing, R; Espeland. M. Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in CVD Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical Trial. Diabetes Care 2016;39(8):1345-55.
4 - Veldhorst, M; Smeets, A; et.al. Protein-induced satiety: effects and mechanisms of different proteins. Physiology & Behavior. 2008. 94: 300-7.
5 - Westerterp- Plantenga, M. The significance of protein in food intake and body weight regulation. Curr Opin Clin Nutr Metab Care (2003), 6, 635-638.
6 - Fromentin, G; Darcel. N; et.al. Peripheral and central mechanisms involved in the control of food intake by dietary amino acids and proteins. Nutrition Research Reviews (2012), 25, 29-39.
7 - Leidy, H; Hoertel, H; et.al. A high-protein breakfast prevents body fat gain, through reductions in daily intake and hunger, in "Breakfast skipping" adolescents. Obesity (2015) 23, 1761–1764.
8 - Acheson, K; Blondel-Lubrano, A; et.al. Protein choices targeting thermogenesis and metabolism. Am J Clin Nutr. 2011 Mar;93(3):525-34.
9 - Pasiakos, S; Cao, J. et.al. Effects of high‐protein diets on fat‐free mass and muscle protein synthesis following weight loss: a randomized controlled trial. 2013,FASEB J. 27, 3837–3847.
10 - Acheson, K; Blondel-Lubrano, A; et.al. Protein choices targeting thermogenesis and metabolism. Am J Clin Nutr. 2011 Mar;93(3):525-34.
11 - Pasiakos, S; Cao, J. et.al. Effects of high‐protein diets on fat‐free mass and muscle protein synthesis following weight loss: a randomized controlled trial. 2013,FASEB J. 27, 3837–3847.
12 - LIU H, ZHANG M, MA Q, et al. Health beneficial effects of resistant starch on diabetes and obesity via regulation of gut microbiota: a review. Food Funct. 2020;11(7):5749-5767.
13 - Position of the Academy of Nutrition and Dietetics: Interventions for the Treatment of Overweight and Obesity in Adults. J Acad Nutr Diet. 2016;116:129-147.
14 - Jensen, M; Ryan, D; et.al.2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. 2014. 129(25)_suppl_2: S102-S138.
15 - Dehghan, P; Gargari, B.P. et.al. Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized controlled clinical trial. Nutrition. 2014 (30):418-423.
16 - DELZENNE NM, CANI PD, NEYRINCK AM. Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data. J Nutr. 2007;137(11 Suppl):2547S-2551S.
17 - LEULIER F, MACNEIL LT, LEE WJ, et al. Integrative Physiology: At the Crossroads of Nutrition, Microbiota, Animal Physiology, and Human Health. Cell Metab. 2017;25(3):522-534.
Este link irá tirá-lo do site de Glucerna que não está sob o controle da Abbott. Não somos responsáveis pelo conteúdo ou processamento de dados pessoais fora do nosso domínio. A Abbott fornece estes links por conveniência e a inclusão de qualquer link não implica endosso do site pela Abbott. O site ao qual você será direcionado pode não ter o tamanho adequado para a sua tela. DESEJA CONTINUAR E DEIXAR ESTE SITE?